Sherman CB et al. implemented the A-VENA Criteria, which involves AFP levels (>1000 ng/dL) and portal vein thrombosis imaging characteristics (venous expansion, enhancement of the thrombus, neovascularization, adjacency to HCC), demonstrating accurate identification of portal vein thrombosis [15]. The gene discussed is AFP; the disease is medical procedure.